Literature DB >> 8989157

A 30-year perspective on alpha 1-antitrypsin deficiency.

S Eriksson1.   

Abstract

The early history of alpha 1-antitrypsin deficiency, in the years between 1962 and 1965, and its impact on the understanding of emphysema abnormalities were reviewed by me in 1989. This report discusses the disease spectrum (including emphysema, liver, and vasculitic diseases) and focuses on the variable clinical expression of the deficiency state. Some new findings that may be relevant to the function of alpha 1-antitrypsin are also considered.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8989157     DOI: 10.1378/chest.110.6_supplement.237s

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  12 in total

1.  Mutant fibrinogen cleared from the endoplasmic reticulum via endoplasmic reticulum-associated protein degradation and autophagy: an explanation for liver disease.

Authors:  Kristina B Kruse; Amy Dear; Erin R Kaltenbrun; Brandan E Crum; Peter M George; Stephen O Brennan; Ardythe A McCracken
Journal:  Am J Pathol       Date:  2006-04       Impact factor: 4.307

2.  A Pulmonary Perspective on GASPIDs: Granule-Associated Serine Peptidases of Immune Defense.

Authors:  George H Caughey
Journal:  Curr Respir Med Rev       Date:  2006-08

3.  [Alpha1-antitrypsin deficiency in Austria: analysis of the Austrian Alpha1-international-registry database].

Authors:  Florian Huber; Karin Schmid-Scherzer; Felix Wantke; Sophie Frantal; Meinhard Kneussl
Journal:  Wien Klin Wochenschr       Date:  2010-07-14       Impact factor: 1.704

Review 4.  Advances in alpha-1-antitrypsin deficiency liver disease.

Authors:  Jeffrey H Teckman; Ajay Jain
Journal:  Curr Gastroenterol Rep       Date:  2014-01

5.  Polymorphisms in the HPC/ELAC-2 and alpha 1-antitrypsin genes that correlate with human diseases in a North Indian population.

Authors:  Ranbir C Sobti; Hitender Thakur; Lipsy Gupta; Ashok K Janmeja; Amlesh Seth; Sharwan K Singh
Journal:  Mol Biol Rep       Date:  2010-02-02       Impact factor: 2.316

6.  Serum alpha1-antitrypsin level and phenotype associated with familial moyamoya disease.

Authors:  Toshiyuki Amano; Satoshi Inoha; Chun-Ming Wu; Toshio Matsushima; Kiyonobu Ikezaki
Journal:  Childs Nerv Syst       Date:  2003-07-25       Impact factor: 1.475

7.  Development of predictive models for airflow obstruction in alpha-1-antitrypsin deficiency.

Authors:  P J Castaldi; D L DeMeo; D M Kent; E J Campbell; A F Barker; M L Brantly; E Eden; N G McElvaney; S I Rennard; J M Stocks; J K Stoller; C Strange; G Turino; R A Sandhaus; J L Griffith; E K Silverman
Journal:  Am J Epidemiol       Date:  2009-09-02       Impact factor: 4.897

Review 8.  Advances in managing COPD related to α1 -antitrypsin deficiency: An under-recognized genetic disorder.

Authors:  Timothy J Craig; Maria Paula Henao
Journal:  Allergy       Date:  2018-07-26       Impact factor: 13.146

9.  Development and results of the Spanish registry of patients with alpha-1-antitrypsin deficiency.

Authors:  Beatriz Lara; Cristian de la Roza; Sara Vilà; Rafael Vidal; Marc Miravitlles
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2007

10.  Results from a large targeted screening program for alpha-1-antitrypsin deficiency: 2003 - 2015.

Authors:  Timm Greulich; Christoph Nell; Christian Herr; Claus Vogelmeier; Viktor Kotke; Stefan Wiedmann; Marion Wencker; Robert Bals; Andreas Rembert Koczulla
Journal:  Orphanet J Rare Dis       Date:  2016-06-10       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.